Alexander Stegh

Medicine & Life Sciences

1. Glioblastoma 100%
2. Glioma 42%
3. Nucleic Acids 41%
4. Apoptosis 36%
5. Neoplasms 33%
6. Effector Caspases 24%
7. Death Effector Domain 18%
8. Caspase 8 17%
9. Heterografts 15%
10. Growth 14%
11. RNA Interference 14%
12. Therapeutics 14%
13. Brain Neoplasms 14%
14. Caspase 3 12%
15. Isocitrate Dehydrogenase 12%
16. Death Domain Receptor Signaling Adaptor Proteins 12%
17. Caspase 7 12%
18. Astrocytoma 12%
19. Receptor Protein-Tyrosine Kinases 12%
20. Proteins 11%
21. Oncogene Proteins 10%
22. Nanoconjugates 9%
23. RNAi Therapeutics 8%
24. Plectin 8%
25. MicroRNAs 8%
26. Nanoparticles 8%
27. palbociclib 8%
28. Typical Teratoid Rhabdoid Tumor 8%
29. dihydroceramide desaturase 8%
30. Atypical Teratoid Tumor 8%
31. Caspase 6 8%
32. Cell Death 7%
33. Crystallins 7%
34. protein kinase C zeta 7%
35. Brain 7%
36. Small Interfering RNA 7%
37. Nanomedicine 7%
38. Mutation 7%
39. DNA Damage 7%
40. RNA Polymerase I 7%
41. DNA Repair 7%
42. Necrosis 7%
43. Penetrance 6%
44. Caspases 6%
45. Catalytic RNA 6%
46. Nanotechnology 6%
47. Temozolomide 6%
48. Ligases 6%
49. DNA 6%
50. Oligonucleotides 6%